| scholarly article | Q13442814 |
| P50 | author | M. Eric Gershwin | Q73297886 |
| Aftab A. Ansari | Q80366411 | ||
| Kazuhito Kawata | Q89739670 | ||
| Weici Zhang | Q114397884 | ||
| Kazuichi Okazaki | Q116772127 | ||
| Yugo Ando | Q117248952 | ||
| Pietro Invernizzi | Q37842572 | ||
| Zhe-Xiong Lian | Q61090146 | ||
| P2093 | author name string | Wenting Huang | |
| Thomas P Kenny | |||
| Qianjin Lu | |||
| Xiao-Song He | |||
| Guo-Xiang Yang | |||
| Patrick S C Leung | |||
| William M Ridgway | |||
| P2860 | cites work | New insights into the role of nuclear factor-KB, a ubiquitous transcription factor in the initiation of diseases | Q23923136 |
| The NF-kappa B and I kappa B proteins: new discoveries and insights | Q24313579 | ||
| miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism | Q24316257 | ||
| Origins and Mechanisms of miRNAs and siRNAs | Q27860822 | ||
| Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells | Q28256740 | ||
| SMAD proteins control DROSHA-mediated microRNA maturation | Q28941771 | ||
| Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21 | Q28975612 | ||
| Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases | Q29547555 | ||
| MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer | Q29616316 | ||
| Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease | Q30434096 | ||
| miRNA profiling of naïve, effector and memory CD8 T cells. | Q33302117 | ||
| Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. | Q33377575 | ||
| MicroRNAs profiling in murine models of acute and chronic asthma: a relationship with mRNAs targets | Q33815996 | ||
| Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease | Q73542905 | ||
| Inflammation anergy in human intestinal macrophages is due to Smad-induced IkappaBalpha expression and NF-kappaB inactivation | Q33911451 | ||
| Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha | Q34065396 | ||
| Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitis | Q34116480 | ||
| Identification of microRNAs associated with ileal and colonic Crohn's disease | Q34159093 | ||
| Selective Upregulation of microRNA Expression in Peripheral Blood Leukocytes in IL-10−/− Mice Precedes Expression in the Colon | Q34229305 | ||
| Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis | Q34766857 | ||
| The microRNA-21−PDCD4 axis prevents type 1 diabetes by blocking pancreatic β cell death | Q35123062 | ||
| The microRNA world: small is mighty | Q35559723 | ||
| DNA damage induces NF-κB-dependent microRNA-21 up-regulation and promotes breast cancer cell invasion | Q36052395 | ||
| The immunobiology of colitis and cholangitis in interleukin-23p19 and interleukin-17A deleted dominant negative form of transforming growth factor beta receptor type II mice | Q36153059 | ||
| Deletion of interleukin (IL)-12p35 induces liver fibrosis in dominant-negative TGFβ receptor type II mice | Q36179395 | ||
| CD8 T Cells Mediate Direct Biliary Ductule Damage in Nonobese Diabetic Autoimmune Biliary Disease | Q37155727 | ||
| MicroRNA in autoimmunity and autoimmune diseases. | Q37280366 | ||
| The type III transforming growth factor-beta receptor negatively regulates nuclear factor kappa B signaling through its interaction with beta-arrestin2. | Q37281661 | ||
| MicroRNAs: key modulators of posttranscriptional gene expression. | Q37339409 | ||
| Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice | Q37358583 | ||
| Expression of microRNA-146 in rheumatoid arthritis synovial tissue | Q37359799 | ||
| Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice | Q37438364 | ||
| Control of microRNA biogenesis by TGFbeta signaling pathway-A novel role of Smads in the nucleus | Q37456016 | ||
| A microRNA-21 surge facilitates rapid cyclin D1 translation and cell cycle progression in mouse liver regeneration | Q38327797 | ||
| Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression | Q38334975 | ||
| The negative costimulatory molecule PD‐1 modulates the balance between immunity and tolerance via miR‐21 | Q38336081 | ||
| Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells | Q38558752 | ||
| MicroRNA-21 targets tumor suppressor genes in invasion and metastasis | Q40013848 | ||
| Mechanistic aspects of NF-kappa B regulation: the emerging role of phosphorylation and proteolysis | Q40410066 | ||
| Transforming growth factor-beta 1 inhibits non-pathogenic Gram negative bacteria-induced NF-kappa B recruitment to the interleukin-6 gene promoter in intestinal epithelial cells through modulation of histone acetylation | Q40658888 | ||
| MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. | Q41412954 | ||
| MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha | Q43467631 | ||
| B cells suppress the inflammatory response in a mouse model of primary biliary cirrhosis. | Q45957513 | ||
| Heterogeneity of dendritic cells in the mouse liver: identification and characterization of four distinct populations. | Q45967937 | ||
| CD4- plasmacytoid dendritic cells (pDCs) migrate in lymph nodes by CpG inoculation and represent a potent functional subset of pDCs. | Q45995466 | ||
| Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice | Q46607067 | ||
| Paradoxical effect of reduced costimulation in T cell-mediated colitis | Q51988674 | ||
| Comparison of microRNA expression using different preservation methods of matched psoriatic skin samples | Q54319254 | ||
| P921 | main subject | microRNA | Q310899 |
| overexpression | Q61643320 | ||
| P304 | page(s) | 111-119 | |
| P577 | publication date | 2013-02-08 | |
| P1433 | published in | Journal of Autoimmunity | Q15716783 |
| P1476 | title | Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-β receptor type II mouse | |
| P478 | volume | 41 |
| Q41221983 | Animal models of primary biliary cirrhosis |
| Q35008069 | Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis |
| Q37511368 | Atrial fibrillation and microRNAs |
| Q37466004 | Block of both TGF-β and IL-2 signaling impedes Neurophilin-1+ regulatory T cell and follicular regulatory T cell development |
| Q35843599 | Circulating microRNA Profiles in Patients with Type-1 Autoimmune Hepatitis |
| Q64254019 | Co-Detection of miR-21 and TNF-α mRNA in Budding Cancer Cells in Colorectal Cancer |
| Q90481797 | Development of microRNA-21 mimic nanocarriers for the treatment of cutaneous wounds |
| Q38797455 | Downregulation of MicroRNA-21 in Colonic CD3+ T Cells in UC Remission |
| Q37057803 | Elastic band resistance training influences transforming growth factor-ß receptor I mRNA expression in peripheral mononuclear cells of institutionalised older adults: the Vienna Active Ageing Study (VAAS). |
| Q39792098 | Endogenous interleukin-22 protects against inflammatory bowel disease but not autoimmune cholangitis in dominant negative form of transforming growth factor beta receptor type II mice |
| Q92707424 | Enhanced expression of miR-21 and miR-150 is a feature of anti-mitochondrial antibody-negative primary biliary cholangitis |
| Q36889204 | Enhancing adoptive T cell immunotherapy with microRNA therapeutics |
| Q38565478 | Epigenetics and Primary Biliary Cirrhosis: a Comprehensive Review and Implications for Autoimmunity |
| Q89966123 | Evaluation of Pathway Activation for a Single Sample Toward Inflammatory Bowel Disease Classification |
| Q91935600 | Examining pathogenic concepts of autoimmune hepatitis for cues to future investigations and interventions |
| Q33754662 | Expression, regulation and function of microRNAs in multiple sclerosis |
| Q38210250 | Extrahepatic autoimmune conditions associated with primary biliary cirrhosis. |
| Q36383011 | Genome-Wide Association Studies in Primary Biliary Cirrhosis |
| Q38331780 | IL-35 and Autoimmunity: a Comprehensive Perspective |
| Q41141524 | Identification of cytokine-induced modulation of microRNA expression and secretion as measured by a novel microRNA specific qPCR assay. |
| Q41592947 | Immunological potential of cytotoxic T lymphocyte antigen 4 immunoglobulin in murine autoimmune cholangitis |
| Q44943070 | Innate immunity drives xenobiotic-induced murine autoimmune cholangitis |
| Q22252398 | Lyme disease: A rigorous review of diagnostic criteria and treatment |
| Q36982325 | MicroRNA-142-5p contributes to Hashimoto's thyroiditis by targeting CLDN1 |
| Q42343232 | MicroRNA-21, T helper lineage and autoimmunity |
| Q26783579 | MicroRNAs in the Cholangiopathies: Pathogenesis, Diagnosis, and Treatment |
| Q42356893 | Open questions in autoimmunity: discussions from the 2013 Controversies in Rheumatology and Autoimmunity Meeting |
| Q91708970 | Plasma Levels of Myocardial MicroRNA-133a Increase by Intraoperative Cytokine Hemoadsorption in the Complex Cardiovascular Operation |
| Q91826723 | Primary biliary cholangitis: pathogenesis and therapeutic opportunities |
| Q40044046 | Review article: next-generation transformative advances in the pathogenesis and management of autoimmune hepatitis |
| Q62675756 | Socioeconomic Deprivation, Adverse Childhood Experiences and Medical Disorders in Adulthood: Mechanisms and Associations |
| Q36299869 | Spaceflight alters expression of microRNA during T-cell activation. |
| Q98291995 | The Role of MicroRNAs in Regulating Cytokines and Growth Factors in Coronary Artery Disease: The Ins and Outs |
| Q39098238 | The challenge of treating orphan disease |
| Q38355697 | The coexistence of Sjögren's syndrome and primary biliary cirrhosis: a comprehensive review |
| Q64112093 | The role of exosomal noncoding RNAs in cancer |
| Q28083164 | Turning 21: Induction of miR-21 as a Key Switch in the Inflammatory Response |
| Q46941311 | Unique topics and issues in rheumatology and clinical immunology |
| Q48542369 | Unmet challenges in immune-mediated hepatobiliary diseases |
| Q28082960 | microRNAs function in CD8+T cell biology |
Search more.